Valuation
- Market cap
- 7,000
- Revenue TTM
- $30,000
- Net income TTM
- $-2,360,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -7,866.67%
- Debt to equity
- 0.00
Trading
- Volume
- 6,000
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 71,440,000
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- $0.70
Company profile
Bioasis Technologies Inc. operates as a biopharmaceutical company. The company utilizes its proprietary xB3 platform to deliver therapeutics across the blood-brain barrier and treat central nervous system disorders in areas of high unmet medical need. Bioasis Technologies Inc. is based in New Haven, Connecticut.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 203 533 7082
- Website
- https://www.bioasis.us
- Address
- 157 Church Street, 19th floor, New Haven, United States
Latest news
No headlines yet.
